Wall Street’s superstars tumbled Monday as a competitor from China threatens to upend the artificial-intelligence frenzy they’ve been feasting on. The S&P 500 dropped 1.5%, dragged down in large part by a 16.

Wall Street’s superstars are tumbling Monday as a competitor from China threatens to upend the artificial-intelligence frenzy they've been feasting on. The S&P 500 was down 1.

Wall Street’s superstars are tumbling Monday as a competitor from China threatens to upend the artificial-intelligence frenzy that’s created a spending bonanza. The S&P 500 was down 1.

Asia markets are mostly higher following gains on Wall Street driven by Tesla, IBM and Meta Platforms after strong profit reports

The memorial services for former President Jimmy Carter began in his home state of Georgia on Saturday, with an emotional motorcade through his hometown of Plains, ahead of his state funeral in ...

Wall Street’s superstars are tumbling Monday as a competitor from China threatens to upend the artificial-intelligence frenzy they've been feasting on. The S&P 500 was down 1.

Wall Street is tumbling on fears the big U.S. companies that have feasted on the artificial-intelligence frenzy are under threat from a competitor in China

Asian shares were mixed in thin Lunar New Year trading on Tuesday after Wall Street’s tech superstars tumbled as a competitor from China raised doubts over the recent artificial-intelligence market frenzy.

NEW DELHI – India’s deep admiration for Jimmy Carter, the former U.S. President who passed away at 100 on December 29, is reflected in the special connection he shared with the country.

The Jimmy Butler trade drama has picked up as his suspension ends. Let’s break down where things stand with Butler. The Miami Heat want out of the Jimmy Butler business, and if that means not getting full price in the trade, they’ll live with that.

Wall Street is tumbling on fears the big U.S. companies that have feasted on the artificial-intelligence frenzy are under threat from a competitor in China

On the winning side of Wall Street were Novo Nordisk’s U.S.-listed shares, which jumped 8.5%. The Danish company reported results from a clinical trial of a treatment for people who are overweight or obese, which could mean bigger profits in the future.